α2β adrenoreceptor 301–303 deletion polymorphism in polycystic ovary syndrome

α2β adrenoreceptor 301–303 deletion polymorphism does not influence basal metabolic rate, insulin resistance or weight gain in Greek women with polycystic ovary syndrome.